Completed PHASE2 INTERVENTIONAL 2-arm NCT04555941

The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD

Cognitive Effects of Theta Burst Stimulation in Mild Cognitive Impairment and Alzheimer's Disease

Sponsor: Taipei Medical University Shuang Ho Hospital

Conditions Alzheimer Disease Cognitive Decline Mild Cognitive Impairment

Interventions intermittent theta burst stimulation

Updated 6 times since 2020 Last updated: Oct 24, 2022 Started: Oct 5, 2020 Primary completion: Jan 31, 2022 Completion: Jan 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Alzheimer Disease and Cognitive Decline and is currently completed. Taipei Medical University Shuang Ho Hospital leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2022 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2021 — Nov 2022 [monthly]

Recruiting PHASE2
Nov 2020 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Oct 2020 — Nov 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Taipei Medical University Shuang Ho Hospital

Data source: Taipei Medical University Shuang Ho Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Taipei City, Taiwan